Yves Agid

85.8k total citations · 17 hit papers
608 papers, 55.1k citations indexed

About

Yves Agid is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Yves Agid has authored 608 papers receiving a total of 55.1k indexed citations (citations by other indexed papers that have themselves been cited), including 348 papers in Neurology, 317 papers in Cellular and Molecular Neuroscience and 149 papers in Molecular Biology. Recurrent topics in Yves Agid's work include Parkinson's Disease Mechanisms and Treatments (291 papers), Neurological disorders and treatments (230 papers) and Neuroscience and Neuropharmacology Research (112 papers). Yves Agid is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (291 papers), Neurological disorders and treatments (230 papers) and Neuroscience and Neuropharmacology Research (112 papers). Yves Agid collaborates with scholars based in France, United States and United Kingdom. Yves Agid's co-authors include Étienne C. Hirsch, F. Javoy‐Agid, B. Pillon, Philippe Damier, Merle Ruberg, Muriel Bonnet, Bruno Dubois, Alexis Brice, Baptiste Faucheux and Ann M. Graybiel and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Yves Agid

600 papers receiving 53.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)

1996 2.0k citations Yves Agid, Bruno Dubois et al. Neurology profile →
The substantia nigra of the human brain

1999 1.4k citations Philippe Damier, Étienne C. Hirsch et al. Brain profile →
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

1989 1.1k citations Yves Agid, Andrew J. Lees et al. profile →
Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

1989 924 citations Yves Agid et al. profile →
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.

1997 862 citations Annick Mouatt‐Prigent, Merle Ruberg et al. PubMed profile →
ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA

1991 858 citations Yves Agid, Andrew J. Lees et al. Brain profile →
Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease

2004 818 citations Pablo Ibáñez, Ebba Lohmann et al. profile →
Clinical and Genetic Abnormalities in Patients with Friedreich's Ataxia

1996 769 citations Alexandra Dürr, Yves Agid et al. profile →
Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease

2010 768 citations Yves Agid et al. profile →
Bilateral Deep-Brain Stimulation of the Globus Pallidus in Primary Generalized Dystonia

2005 739 citations Marie Vidailhet, Jean‐Luc Houéto et al. profile →
Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats

1996 706 citations Alexandra Dürr, Giovanni Stévanin et al. profile →
The Mental Representation of Hand Movements After Parietal Cortex Damage

1996 667 citations Yves Agid et al. profile →
Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion

1997 599 citations Gilles David, Giovanni Stévanin et al. profile →
Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease

2000 591 citations Baptiste Faucheux, Annick Mouatt‐Prigent et al. profile →
Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson disease

1997 591 citations Merle Ruberg, Baptiste Faucheux et al. profile →
Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease

1983 591 citations Bruno Dubois, Yves Agid et al. profile →
Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias

1995 540 citations Giovanni Stévanin, Gilles David et al. profile →

Peers

Countries citing papers authored by Yves Agid

Since Specialization

Citations

This map shows the geographic impact of Yves Agid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Agid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Agid more than expected).

Fields of papers citing papers by Yves Agid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves Agid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Agid. The network helps show where Yves Agid may publish in the future.

Co-authorship network of co-authors of Yves Agid

This figure shows the co-authorship network connecting the top 25 collaborators of Yves Agid. A scholar is included among the top collaborators of Yves Agid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yves Agid. Yves Agid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	La genèse des neurosciences 2021 ·médecine/sciences ·(unknown), (unknown), Yves Agid	0
2	Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo‐controlled, randomized, double‐blind, cross‐over study 2010 ·Movement Disorders ·Olivier Rascol, Jean‐Philippe Azulay, Olivier Blin, Muriel Bonnet, Christine Brefel‐Courbon, Pierre Césaro, Philippe Damier, Bérengère Debilly, F. Durif, Monique Galitzky, Jean‐Marie Grouin, (unknown), Gabriel Villafane, (unknown), Yves Agid	21
3	A Multitracer Dopaminergic PET Study of Young-Onset Parkinsonian Patients With and Without Parkin Gene Mutations 2009 ·Journal of Nuclear Medicine ·Maria-João Ribeiro, Stéphane Thobois, Ebba Lohmann, Sophie Tézenas du Montcel, Suzanne Lesage, Antoine Pélissolo, Bruno Dubois, Luc Mallet, Pierre Pollak, Yves Agid, Emmanuel Broussolle, Alexis Brice, Philippe Rémy, (unknown)	29
4	Are parkin patients particularly suited for deep‐brain stimulation? 2008 ·Movement Disorders ·Ebba Lohmann, Marie‐Laure Welter, Valérie Fraix, Paul Krack, (unknown), (unknown), Marie‐Laure Tanguy, Jean‐Luc Houéto, Valérie Mesnage, Pierre Pollak, Alexandra Dürr, Yves Agid, Alexis Brice, (unknown)	29
5	Apathy following subthalamic stimulation in Parkinson disease: A dopamine responsive symptom 2008 ·Movement Disorders ·Virginie Czernecki, Michaël Schüpbach, (unknown), Richard Lévy, Éric Bardinet, Jérôme Yelnik, Bruno Dubois, Yves Agid	155
6	How can drug discovery for psychiatric disorders be improved? 2007 ·Nature Reviews Drug Discovery ·Yves Agid, György Buzsáki, David M. Diamond, R. S. J. Frackowiak, Jay N. Giedd, Jean‐Antoine Girault, Anthony A. Grace, Jeremy J. Lambert, Husseini K. Manji, Helen S. Mayberg, Maurizio Popoli, Alain Prochiantz, Gal Richter‐Levin, Péter Somogyi, Michael Spedding, Per Svenningsson, Daniel R. Weinberger	178
7	Neurosurgery at an earlier stage of Parkinson disease 2006 ·Neurology ·Michaël Schüpbach, David Maltête, Jean Luc Houeto, Sophie Tézenas du Montcel, Luc Mallet, Marie Laure Welter, Marcela Gargiulo, Cécile Béhar, A. M. Bonnet, Virginie Czernecki, B. Pidoux, S. Navarro, Didier Dormont, Philippe Cornu, Yves Agid	164
8	Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa 2006 ·Brain ·Pablo Ibáñez, Suzanne Lesage, Ebba Lohmann, Stéphane Thobois, Giuseppe De Michele, Michel Borg, Yves Agid, Alexandra Dürr, Alexis Brice	123
9	Control of vertical components of gait during initiation of walking in normal adults and patients with progressive supranuclear palsy 2006 ·Gait & Posture ·Marie‐Laure Welter, Manh Cuong, Nathalie Chastan, F. Torny, Frédéric Bloch, Sophie Tézenas du Montcel, Yves Agid	37
10	Neurosurgery in Parkinson disease 2006 ·Neurology ·Michaël Schüpbach, Marcela Gargiulo, M.-L. Welter, Luc Mallet, Cécile Béhar, Jean Luc Houeto, David Maltête, Valérie Mesnage, Yves Agid	281
11	Levodopa-responsive dystonia 2000 ·Brain ·Jean‐Pol Tassin, Alexandra Dürr, Muriel Bonnet, Roger Gil, Marie Vidailhet, Christoph B. Lücking, (unknown), Franck Durif, (unknown), Bernard Échenne, Jacques Motté, A Lagueny, Lucette Lacomblez, (unknown), (unknown), Yves Agid, Alexis Brice	123
12	Calpastatin immunoreactivity in the monkey and human brain of control subjects and patients with Parkinson's disease 2000 ·The Journal of Comparative Neurology ·Annick Mouatt‐Prigent, Jan‐Olof Karlsson, Jérôme Yelnik, Yves Agid, Étienne C. Hirsch	15
13	Somatotopical organization of striatal activation during hand and toes movements: A 3T fMRI study 1997 ·NeuroImage ·Stéphane Lehéricy, Pierre‐François Van de Moortele, E. Löbel, Anne‐Lise Paradis, Marie Vidailhet, Yves Agid, C. Marsault, Denis Le Bihan	1
14	The gene for autosomal dominant cerebellar ataxia type II is located in a 5-cM region in 3p12-p13: genetic and physical mapping of the SCA7 locus. 1996 ·PubMed ·Gilles David, Paola Giunti, N. Abbas, P. Coullin, Giovanni Stévanin, (unknown), Robert M. Gemmill, J. Weissenbach, Nicholas Wood, (unknown), Harry A. Drabkin, A E Harding, Yves Agid, Alexis Brice	52
15	Expression of glutamate receptors in the human and rat basal ganglia: Effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in parkinson's disease and rat with 6-OHDA lesion 1996 ·The Journal of Comparative Neurology ·Véronique Bernard, Alejandra Gardiol, Baptiste Faucheux, Bertrand Bloch, Yves Agid, Étienne C. Hirsch	76
16	Current Trends in the Treatment of Parkinson's Disease 1992 ·Yves Agid, Joseph Jankovic	1
17	Effects of a selective partil D₁ agonist, CY 208‐243, in de novo patients with Parkinson disease 1992 ·Movement Disorders ·Murat Emre, U. K. Rinne, A Rascol, Andrew J. Lees, Yves Agid, X. Lataste	34
18	Choline acetyltransferase activity and [ 3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions 1990 ·Neuroscience ·Merle Ruberg, Willy Mayo, Alexis Brice, Charles Duyckaerts, J J Hauw, H. Simon, M. LeMoal, Yves Agid	78
19	[Acetylcholine receptors (author's transl)]. 1979 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·G. Kato, Yves Agid	4
20	Monoamine oxidase and aldehyde dehydrogenase activity in the striatum of rats after 6‐hydroxydopamine lesion of the nigrostriatal pathway 1973 ·British Journal of Pharmacology ·Yves Agid, F. Javoy, Moussa B. H. Youdim	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact